2026年CES即将开幕，新一轮AI浪潮即将掀起，属于中国企业的AI+硬件出海之门持续敞开。36氪将携手同创伟业和创业观察栏目「摊牌」带您直击2026 CES现场。 图：haivivi创始人李勇，同创伟业投资人王晶，云鲸创始人张峻彬 "新一代的硬件创业公司，从踏上创业的第一天起，脑子里就装着一张世界地图。如果连做高溢价品牌的野心都没有，那就太没想象力了"，如今这句话正成 为越来越多科技、硬件创业者的共识。 全球视野是新一代硬件创业者的共同特质。背靠全球完整、高效的工业体系和完善的供应链网络，新一代具备品牌影响力的中国硬件公司在远洋搏击的战场 上捷报频传。 根据海关总署发布的数据，2025年前三季度我国高技术产品出口额达到3.75万亿，同比增长11.9%。 对中国企业来说，CES几乎成为出海亮相的第一站。越来越多智能硬件公司、AI 创业团队，都把 CES 视为进入全球市场的"首堂必修课"。这场"科技界的春 晚"，也是科技企业开年的最佳营销场域。 AI是近几年CES的核心议题，CES也是观察AI行业进化迭代的窗口。摩根士丹利预判，2026年将成为AI科技硬件迎来爆发式增长的关键之年。而这场爆发的 前哨战，将在20 ...

作者丨冯汝梅 编辑丨关雎 图源丨Midjourney AI医疗赛道又跑出一个估值近250亿元的独角兽。 近期，AI医疗初创公司Hippocratic AI在最新一轮融资中获得1.26亿美元投资。本轮融资后，公司估值飙升至35亿美元（约合人民币249亿元）。而在2025 年1月完成B轮融资时，公司估值仅为16.4亿美元，不到一年时间估值实现翻倍，并入选了《财富》全球人工智能创新者50强、2025年AI医疗TOP30企业。 Hippocratic AI是一家医疗领域大语言模型开发的人工智能公司，成立于2023年5月，总部位于美国。公司名称源自医学界的希波克拉底誓言（Hippocratic Oath），这是全球医学生毕业时宣誓的核心医学伦理准则，核心是"普济众生，不伤害患者"。 不到2年，Hippocratic AI已与六个国家的50多个大型卫生系统、制药企业合作，完成了超过1.15亿次临床患者互动，且未出现安全问题。公司2025年年初 推出的"Healthcare AI Agent App Store"，允许无编程基础的医生、护士直接参与AI工具开发，快速定制适配具体需求的医疗AI应用，目前已覆盖超1000种 非 ...

公司主营业务为功能性树脂和功能性涂层材料的研发、生产和销售，以分子结构设计为技术原点，深耕 核心功能性树脂的关键技术研发与产业化应用，构建起功能性树脂与功能性涂层材料两大技术平台，构 筑起核心竞争壁垒。 功能性树脂是功能性涂层材料的关键材料，决定了功能性涂层材料的基础性能，其设计和放大生产具有 较高的技术和工艺门槛。功能性涂层材料涂覆于基材表面，赋予基材特定功能，广泛应用于家电、包 装、新能源、电子等领域。公司对外销售的产品主要为功能性涂层材料。 依托功能性树脂和涂层材料双技术平台的整合协作，紧密结合国民经济的发展脉络及关键材料需求图 谱，公司成功开发具备光学调控、导电导热、力学增强、防腐耐候等多元特性的涂层材料体系，已形成 面向家电、包装、新能源、电子四大下游应用场景的"1+1+N"产业布局体系。 公司各主要产品在各自的细分领域均已取得一定的市场地位，具有较强竞争优势。在换热器节能涂层材 料和金属包装铝盖涂层材料领域，公司的国内市场占有率分别超过了60%和30%， 智通财经APP获悉，12月9日，广州慧谷新材料科技股份有限公司(简称：慧谷新材)通过深交所创业板上 市委会议。IPO的保荐人为中信证券，拟募资9 ...

截至收盘，创业板成长指数上涨1.6%，创业板指数上涨0.6%，创业板中盘200指数下跌0.5%，盘面上，元件、CPO、PCB等算力硬件概念表现强势，胜宏科 技涨超10%，中际旭创涨超6%，新易盛涨超3%，天孚通信涨超1%、再创历史新高。 每日经济新闻 ...

Market Overview - The A-share market experienced a slight decline, with the Shanghai Composite Index down by 0.37%, the Shenzhen Component Index down by 0.39%, and the ChiNext Index up by 0.61% [6] - The total trading volume across both markets was 1.9 trillion yuan, a decrease of 132.7 billion yuan compared to the previous day [6] - The number of stocks that rose was 1,308 out of a total of 4,058 stocks listed [6] Institutional Insights - Galaxy Securities suggests that the long-term stable operation foundation of the A-share market may be further solidified due to policy dividends and industrial upgrades [2][6] - Dongguan Securities indicates that ongoing domestic policies aimed at expanding domestic demand and stabilizing employment are driving economic recovery, alongside expectations of interest rate cuts from the Federal Reserve, which supports the market [2][6] - Guotai Junan predicts that after a prolonged period of sideways movement, the Chinese stock market may enter a year-end rally, with indices expected to rise to new levels [2][6] Investment Products - Huabao Fund has launched a series of three major broad-based ETFs tracking the China Securities A50, A100, and A500 indices, providing investors with diverse options for bullish exposure to China [2][6] - The A50 ETF focuses on 50 leading companies, while the A100 ETF encompasses the top 100 industry leaders, and the A500 ETF covers a broader range of 500 stocks [2]

Group 1 - The computer industry is entering a new phase of AI competition characterized by "strong reasoning + native multimodal" capabilities, with significant advancements from models like Kimi K2 Thinking, Gemini 3, and DeepSeek-V3.2 [1] - The demand for AI computing power is expected to grow due to the effectiveness of scaling laws in the electronics industry, with PCB demand likely to maintain high growth, driven by capacity release and product structure optimization [1] - The humanoid robot industry is transitioning from concept validation to commercialization, presenting opportunities for key component and complete machine companies to benefit from a "Davis double hit" [1] Group 2 - The Science and Technology Innovation ETF (588360) tracks the Science and Technology Innovation 50 Index (931643), which has a daily fluctuation of 20%, selecting 50 emerging industry stocks with large market capitalization and good liquidity from the Sci-Tech and ChiNext boards [1] - The index focuses on companies with strong technological attributes and high growth potential, covering core sectors such as information technology, new energy, and biomedicine, aiming to reflect the overall performance of listed companies in China's frontier industries [1]

Core Viewpoint - The launch of the National Medical Insurance Administration's drug price registration system reflects a strong support for pharmaceutical innovation and aims to enhance the modernization of drug price governance in China [1] Group 1: Drug Price Registration System - The new system operates on the principles of "one location for acceptance, nationwide sharing, and global openness," providing drug price registration and inquiry services for domestic and foreign pharmaceutical companies [1] - This initiative is expected to facilitate the international expansion of Chinese innovative drugs and attract high-quality new drugs from abroad into the Chinese market [1] Group 2: Market Dynamics - The importance of China's large-scale market in the global pharmaceutical landscape is increasing, leading to higher demands for improving the drug price governance system [1] - The pharmaceutical industry is experiencing a structural recovery trend, with both supply and demand sides reaching a turning point [1] Group 3: Investment Opportunities - The Guotai Medical ETF (159377) tracks the innovative pharmaceutical index (399275), which has a daily fluctuation of up to 20% [1] - This index focuses on innovative pharmaceutical sectors, selecting listed companies with high R&D investment and strong innovation capabilities, reflecting the overall performance of leading companies in the pharmaceutical industry with growth and technological attributes [1]

Market Performance - The ChiNext Index rose by 0.61%, closing at 3209.60 points, with a total trading volume of 535.03 billion yuan, a decrease of 55.10 billion yuan from the previous trading day [1] - Among the tradable ChiNext stocks, 349 stocks closed higher, with 13 stocks rising over 10%, including Zhongchuang Environmental Protection and Hengxin Dongfang, while 1021 stocks closed lower [1] Turnover Rate - The average turnover rate for the ChiNext today was 3.78%, with 40 stocks having a turnover rate exceeding 20% [1] - The highest turnover rate was for Hongxiang Co., which closed up 5.60% with a turnover rate of 52.25% and a trading volume of 3.398 billion yuan [1] Sector Analysis - Among the high turnover stocks, the electronics sector had the most representation, with 10 stocks listed, followed by the computer and machinery equipment sectors with 6 and 5 stocks, respectively [2] Institutional Activity - Eight high turnover ChiNext stocks appeared on the Dragon and Tiger List, with significant institutional buying in Hengxin Dongfang and Deyi Culture, net buying amounts were 53.06 million yuan and 15.40 million yuan, respectively [3] - The top net buying stocks by brokerage firms included Shanxi Huada and Hongjing Technology, with net buying amounts of 94.66 million yuan and 87.70 million yuan, respectively [3] Capital Flow - Among high turnover stocks, 18 stocks saw net inflows from major funds, with the highest inflows in Qianzhao Optoelectronics, Hengxin Dongfang, and Hongjing Technology, with net inflows of 273 million yuan, 216 million yuan, and 210 million yuan, respectively [4] - The stock with the highest expected net profit growth for 2025 was Nannetwork Digital, with a projected net profit of 586 million yuan, representing a year-on-year increase of 2.76% [4]

来源：品牌观察官 东北人开的重庆面馆，撑起了一个IPO。 遇见小面冲击"中式面馆第一股"成功了。 12月5日，广州遇见小面餐饮股份有限公司（下称"遇见小面"）正式登陆港股。 图源：网络 遇见小面三位创始人 这次遇见小面上市，发行价定在7.04港元/股，总共卖了9736万股，预计所得款项总额为6.85亿港币。 然而资本市场的反应却泼了一盆冷水。 上市即破发，开盘股价5港元/股，较7.04港元/股的发行价下跌28.98%。 截至收盘，遇见小面股价报5.08港元/股，较发行价下跌了27.84%，对应总市值约为36.10亿港元，未能迎来市场开门红。 图源：雪球 这其中或许离不开餐饮行业大环境的寒意，这种寒意直接传导到了资本市场。 近期港股市场餐饮板块表现疲软，部分头部餐饮企业股价持续下跌，市场对餐饮股的信心不足。 截至目前，大家乐集团（00341.HK）年内股价累计跌幅超25%，大快活集团（00052.HK）股价累计下跌超16%。 2025年以来，九毛九（09922.HK）、海底捞（06862.HK）等餐饮龙头股价也均出现不同程度下滑，市场对餐饮企业的增长预期趋于谨慎。 这种大环境下，也必然影响了投资者对遇见小面的信 ...

【博时市场点评12月9日】两市涨跌不一，创业板继续上涨 简评：近期地缘政治、全球流动性预期等因素加剧贵金属价格波动，交易所风险提示释放出对市场过热 投机倾向的关注，旨在预防潜在的非理性波动，引导市场回归理性定价。投资者需密切关注宏观面变化 及政策导向，做好风险对冲。 市场复盘 12月9日，A股三大指数涨跌不一。截至收盘，上证指数报3909.52点，下跌0.37%；深证成指报13277.36 点，下跌0.39%；创业板指报3209.60点，上涨0.61%；科创100报1389.96点，下跌0.90%。申万一级行业 中，综合、通信、电子涨幅靠前，分别上涨3.45%、2.23%、0.78%；有色金属、钢铁、房地产跌幅靠 前，分别下跌3.03%、2.47%、2.10%。1290只个股上涨，3855只个股下跌。 每日观点 今日沪深三大指数涨跌不一，创业板涨0.61%，两市成交较前一日缩量至1.91万亿。中共中央政治局昨 日召开会议，对2026年经济工作进行部署，并为后续即将召开的中央经济工作会议定调。与往年这个时 间的政治局会议相同，此次会议主要以经济工作取得的成效为主，包括经济运行总体平稳、新质生产力 稳步发展、重点 ...